Medications

FDA drug approvals reached 18-year high in 2014

The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.

Health

Caregiver's health is strong predictor of orphan's health

The health of a caregiver is the most important predictor of orphan health, according to a new Duke University study that spans five less-wealthy nations in Africa and Asia. More important than an orphan's geographic location, ...

Health

Justifying insurance coverage for orphan drugs

How can insurers justify spending hundreds of thousands of dollars per patient per year on "orphan drugs" – extremely expensive medications for rare conditions that are mostly chronic and life-threatening -- when this ...

Medications

Pharma's niche focus spurs US aid for antibiotics

(AP) -- The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new treatments for diseases ...

Diseases, Conditions, Syndromes

Pirfenidone: Extent of added benefit assessed

Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011. ...

HIV & AIDS

Program improves health of orphans of Rwandan genocide

Rwandan children who lived through the horrors of the 1994 genocide may suffer from psychological trauma that makes them more vulnerable to health problems, such as HIV infection. But a medical school study shows that with ...

page 3 from 4